Master Resale Rights Downloads
Master Resale Rights Downloads Offers A Huge Selection Of PLR & MRR Products For Your Business. We Support All Types Of Niches Whether Require PLR Articles, Royalty Free Photos Or Even Full Minisite Packages And Best Of All It Comes With Free Updates.
Master Resale Rights Downloads
Learn Guitar 4 Kids
Learn To Play Guitar With This Book Specifically Designed For Beginners In The 6 To 9 Year Age Group. A Simple And Engaging Way To Learn Guitar For Young Children. Covers Melody Playing With Notes Using Clear Diagrams And Simple Songs.
Learn Guitar 4 Kids
LiveWire Mobile, Inc. (LVWR: OTC Link) | Livewire Mobile, Inc. Closes $800,000 In New Funding
Livewire Mobile Closes $800,000 in New Funding
LITTLETON, MASS., May 2012, Livewire Mobile, Inc., (otcmarkets: LVWR), the one-stop digital content solutions provider for carriers, consumer device manufacturers, media companies, and consumers, today announced that the Company closed debt funding totalling $800,000 in senior secured convertible notes with three existing note holders on May 2, 2012. The notes mature on June 8, 2013, bearing interest at 10% per annum, and are convertible into common stock at any time at the option of the note holders at an initial conversion rate (subject to adjustment) of $0.37 per common share. The notes are secured by all of the assets of the Company and contain certain operating and financial covenants applicable to the Company. Quarterly interest on the new notes is earned from the date of issuance and is payable the first day of each following quarter,beginning July 1, 2012.
This brings the total of senior secured notes funding raised to $4.4 million since June 2011.
Matthew Stecker, President and CEO of Livewire Mobile, said “We are pleased to close this additional round of funding, and enjoy the continued support of our investors as we continue the transition of our business to support the global smartphone explosion.”
For more information contact:
Livewire Mobile Media and Investor Relations:
Investor
Todd Donahue, CFO
e: todd.donahue@livewiremobile.com
t: +1 978 742 3167
Media
North America:Erin Schweppe, VP Marketing
e: erin.schweppe@livewiremobile.com
t: +1 978 742 3155
EMEA: Dave Moreau, COO
e:dave.moreau@livewiremobile.com
m: +44 7887 645 835
twitter: @DaveMoreau
About Livewire Mobile
Livewire Mobile, Inc. (otcmarkets: LVWR) is a Mobile Internet powerhouse with one of the most comprehensive one-stop digital entertainment solutions for network operators, consumer device manufacturers, brands and media companies entering the mobile market. The company’s integrated suite of content services includes applications, video games, ringback tones, ringtones, DRM-free full-track music, e-books and more as well as application and portal development, mobile advertising solutions,integrated content publishing and merchandising, and turnkey managed VAS operations. For more information, please visit www.livewiremobile.com.
Livewire Mobile is a registered servicemark of Livewire Mobile, Inc. All other trade names are the property of theirrespective owners.
Statements other than historical facts included or referred to in this Press Release are “forward-looking statements”including forward-looking statements about the transition of our business to support the global smartphone explosion. These statements are based on management’s expectations as of the date of this document and are subject tou ncertainties and changes in circumstances. Actual results may differ materially from these expectations due to risks and uncertainties including,but not limited to, uncertainties with respect to the transition of our business to support the global smartphone explosion. In addition, while management may elect to update forward-looking statements at some point in in the future, management specifically disclaims any obligation to do so, even if its estimates change. Any reference to our website in this press release is not intended to incorporate the contents thereof into this press release or any other public announcement.
****
Link to OTC Markets Group – News, Filings & Corporate Actions
Living Cell Technologies Ltd. (LVCLY: OTC Link) | LCT’s DIABECELL trial extension approved
Living Cell Technologies Limited
Company Announcement
LCT’s DIABECELL® trial extension approved
17 May 2012: Sydney, Australia & Auckland, New Zealand – Living Cell Technologies Limited (ASX: LCT; OTCQX: LVCLY) has received approval from the New Zealand Minister of Health to trial a higher dose of its DIABECELL® product.
A Phase 2 clinical trial of DIABECELL for treating unstable type 1 diabetes has been underway in New Zealand for two years. Establishing optimal dosage is a central aspect of the trial. This permission to proceed with the highest dose in two further patients will allow firm conclusions to be drawn about the optimum single dose. The New Zealand data combined with the results from a similar trial being conducted in Argentina, which uses two sequential doses, will ensure the optimum design of a pivotal trial. The company expects to start this in Q1 2013.
Professor Bob Elliott, LCT’s Medical Director, said, “This approval, with additional ethical approval, allows us to build a more complete picture of the best procedure. Our preliminary report presented in Prague last year, which suggested more benefit from some doses than others, can be crystallised.”
Dr Andrea Grant, LCT’s CEO, said, “This extension brings the number of patients in each of the trial groups to four, facilitating the selection of the optimal dose. The data collection and follow up period for patients who have already received transplants in New Zealand ends in June 2012. Following that we will review and analyse that data and we hope to be able to provide a more detailed update on the clinical outcomes from the New Zealand trial towards the end of the third quarter of 2012.”
LCT’s Phase II clinical trial groups for DIABECELL
Trial group | Group 1 | Group 2 | Group 3 | Group 4 |
IEQ/kg* dosage | 10,000 | 15,000 | 20,000 | 5,000 |
Number of patients | 4 | 4 | 4 | 4 |
*Trial dosage is measured in Islet Equivalents per kilogram body weight, or IEQ/kg. This is the number of pig islet cells that are implanted into the patient’s body.
Ends
For further information: www.lctglobal.com
At the company: Dr Andrea Grant, Chief Executive Tel: +64 9 270 7941 Mobile: +64 21 078 5421 Prof Bob Elliott Tel: +64 9 276 2690 Mobile: +64 027 292 4177 | Media enquiries: Sally Raudon Botica Butler Raudon Partners Tel: +64 9 303 3862 Mobile: +64 21 402 502 |
About Living Cell Technologies
LCT leads the world in cell transplant research and has implemented a business model that supports the discovery and advancement of products through preclinical and early clinical development. LCT aims to secure a major pharmaceutical partner to co-develop products through Phase II and pivotal studies, and ultimately market introduction. Value is returned to LCT principally through an ownership share of downstream product profits. LCT is incorporated in Australia. Research and development, operations and manufacturing facilities are based in New Zealand.
LCT Disclaimer
This document contains certain forward-looking statements, relating to LCT’s business, which can be identified by the use of forward-looking terminology such as “promising,” “plans,” “anticipated,” “will”, “project”, “believe”, “forecast”, “expected”, “estimated”, “targeting”, “aiming”, “set to,” “potential,” “seeking to,” “goal,” “could provide,” “intends,” “is being developed,” “could be,” “on track,” or similar expressions, or by express or implied discussions regarding potential filings or marketing approvals, or potential future sales of product candidates. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no assurance that any existing or future regulatory filings will satisfy the FDA’s and other health authorities’ requirements regarding any one or more product candidates nor can there be any assurance that such product candidates will be approved by any health authorities for sale in any market or that they will reach any particular level of sales. In particular, management’s expectations regarding the approval and commercialization of the product candidates could be affected by, among other things, unexpected clinical trial results, including additional analysis of existing clinical data, and new clinical data; unexpected regulatory actions or delays, or government regulation generally; our ability to obtain or maintain patent or other proprietary intellectual property protection; competition in general; government, industry, and general public pricing pressures; and additional factors that involve significant risks and uncertainties about our products, product candidates, financial results and business prospects. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein as anticipated, believed, estimated or expected. LCT is providing this information and does not assume any obligation to update any forward-looking statements contained in this document as a result of new information, future events or developments or otherwise.
Link to OTC Markets Group – News, Filings & Corporate Actions
BullQuake: $OSUR on watch closed yesterday at 9.10
BullQuake: $OSUR on watch closed yesterday at 9.10
Link to Twitter / BullQuake
Flanders Corp. (FLDR: OTC Link) | FLANDERS CORPORATION ANNOUNCES CLOSING OF MERGER
Flanders Corporation, one of the largest manufacturers of air filters, air handling and containment systems, and related products in North America, today announced the completion of its acquisition through merger by an affiliate of Insight Equity Holdings LLC (Insight Equity), a middle-market private equity firm. The transaction was previously announced on March 19, 2012.
The transaction was approved by the company’s shareholders at a special meeting held on April 27, 2012, with approximately 97% of the voted shares and 83.7% of the company’s total outstanding shares of common stock as of the record date voting to approve the merger. Under the terms of the merger agreement, the company’s shareholders will receive $4.40 in cash for each share of the company’s common stock that they held. The company’s common stock will cease trading on the OTC/QX and will be delisted as of the close of markets on May 16, 2012.
Shareholders of record will receive a letter of transmittal and instructions on how to surrender their stock certificates in exchange for the $4.40 per share merger consideration. Shareholders of record should wait to receive the letter of transmittal before surrendering their stock certificates.
Commenting on the closing of the merger, Harry Smith, who will remain the Chief Executive Officer of Flanders, said, “While the last four years have been a challenging journey, to have our shareholders recognize the value created is gratifying to our team. All the employees of Flanders and I appreciate the support of our shareholders over these last several years.”
Mr. Smith continued, “As we now open a fresh chapter with our new partner, Insight Equity, we look to increasing our levels of customer service, brand positioning and overall market leadership. This is a very exciting time to be with Flanders.”
Brad Buser, a Vice President of Insight Equity commented “We are excited to partner with the Flanders management team to continue to create long-term value in the air filtration industry. This management team’s dedication to growing their business through unparalleled customer service and value-added products is a key reason for Insight’s interest in Flanders. We believe our hands-on collaborative approach will allow us to complement the team in several areas, including the sourcing of raw materials, which will bring additional value to Flanders and its customers.”
About Flanders
Flanders is a leading air filtration products manufacturer. Flanders’ products are utilized by many industries, including those associated with commercial and residential heating, ventilation and air conditioning systems, semiconductor manufacturing, ultra-pure materials, biotechnology, pharmaceuticals, synthetics, nuclear power and nuclear materials processing. For further information on Flanders and its products, visit its web site at http://www.flanderscorp.com or contact John Oakley at 252-946-8081.
About Insight Equity
Insight Equity (www .insightequity.com) makes controlling investments in strategically viable, middle market, asset intensive companies across a wide range of industries. Insight Equity specializes in partnering with companies in complex and challenging situations, including corporate divestitures, aggressive growth opportunities, restructurings, and transitions from private family ownership. The firm leverages a proven, collaborative value creation model to facilitate operating enhancements and growth.
Note on Forward-Looking Statements
This press release contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, including but not limited to, statements about expectations for Flanders’ future business performance. These forward-looking statements involve certain risks and uncertainties that could cause actual results to differ materially from those indicated, such as an inability to achieve benefits anticipated as a result of the merger. The Company assumes no obligation to update any forward-looking statement contained in this press release.
Link to OTC Markets Group – News, Filings & Corporate Actions
Passport Potash, Inc. (PPRTF: OTC Link) | Jerry Aiken Appointed to Board of Directors
608, 1199 West Pender Street
Vancouver, BC V6E 2R1
Tel: (604)687-0300 Fax: (604) 687-0151
www.passportpotash.com
PASSPORT POTASH INC.
(TSX.V – PPI)
Jerry Aiken Joins Passport Potash Board ofDirectors
VANCOUVER,BRITISH COLUMBIA–(Marketwire – May 16, 2012) - Passport Potash, Inc. (TSXVENTURE:PPI)(OTCQX:PPRTF) is pleased to announce the appointment ofprofessional geologist Jerry Aiken to the Company’s Board of Directors.
Mr. Aiken has more than 41 years ofexperience in mineral exploration involving base metals, precious metals, andindustrial minerals. He has beeninvolved in project generation, geologic mapping, geochemical evaluation, drillprogram supervision, and regional program management throughout the westernUnited States, Canada, Mexico, South America and parts of Europe.
Since 2005, Mr. Aiken has been working asa consulting geologist involved in the evaluation of mineral properties and thewriting and reviewing of NI 43-101 technical reports and PFS/FS technicalreports. Prior to beginning work as aconsulting geologist, Mr. Aiken worked for 29 years for US Borax (Rio TintoExploration) (“Borax”) in Tucson, Arizona and Valencia, California. Before focusing his career in borates, potashand lithium he worked for five years for ASARCO Exploration beginning in1970. Mr. Aiken has conducted andimplemented exploration programs for borates, potash, lithium and otherindustrial minerals.
A review of Mr.Aiken’s potash experience, beginning in the mid-1970s, shows that he hasevaluated several potash holdings and mines located in the Carlsbad district,New Mexico, and the Paradox Basin, Utah. His experience in that regard resultedin his evaluating the brine potential in the Paradox Basin.
Subsequent to hiswork in the Paradox Basin Mr. Aiken evaluated potash projects in the SouthAmerican Alta Plano and a number of brine projects for potash and other industrialminerals. In addition to his potashevaluation, several ‘hard rock’ projects were evaluated by Mr. Aiken in bothSouth America, (Argentina) and North America (both in the US and Canada).
Mr. Aiken graduatedin 1966 with a Bachelor of Science degree in Geology from Western MichiganUniversity. He also completed coursework in the MastersProgram in Exploration Geology from the University of Idaho. Mr. Aiken is aRegistered Professional Geologist in the State ofWashington.
PassportPotash President and CEO Joshua Bleak commented: “We are happy to welcomeJerry Aiken to our Board. We have beenworking with Jerry as a consultant since the beginning of this year and hisinput has been invaluable. Hissignificant experience in the potash industry provides a huge benefit to theCompany. We look forward to workingtogether with Jerry on movingthis project forward.”
The Company further announces that it hasreceived notice of resignation from Stephen Butrenchuk as a Director andQualified Person of the Company. TheBoard of Directors would like to thank Mr. Butrenchuk for his services.
The Company also announces that Mr. Tim Henneberry, a memberof Passport’s advisory board, is now serving as its Qualified Person.
About the Holbrook Potash Project
PassportPotash Inc. is a TSX-listed resource company engaged in the exploration anddevelopment of advanced potash properties. Passport has acquired a strategicposition in the Holbrook Basin with land holdings encompassing over 86,000acres. In addition, Passport has a cooperative agreement with the Hopi Tribe,allowing the company to access and conduct certain exploration activities on anadditional 12,853 acres of privately held Hopi land (not reservation) whileallowing the tribe to share in the study results. For more informationregarding the Holbrook Basin, see
http://www.azgs.az.gov/arizona_geology/Summer%2008.pdf orvisit our website at www.passportpotash.com
Quality Assuranceand Quality Control
The standard operatingand quality assurance procedures followed by Passport Potash employees havebeen instituted to make sure that all sampling techniques and results meetinternational reporting standards. Coring starts when the first significant gypsum interval (Upper SupaiFormation) is intersected. Informationabout the drill holes and the on-site core descriptions are conducted accordingto international standards (depth intervals, recovery %, lithology, structure,alteration, rock type, weathered profile, sample intervals, remarks). Onsite field geologists collect the cuttings,bag and label them and place a small sub-sample into a chip tray for furthertreatment. Directly after beingretrieved the cores are measured, cleaned, filed logged, packed in plastic polysheeting and placed into sequentially numbered and labeled core boxes. Material is temporarily stored prior totransfer to the core facility in Apache Junction, Arizona, where significantintervals are dry cut in half. Half coresamples are then bagged and carefully packed into boxes and shipped to theSaskatchewan Research Council in Saskatoon.
Passport is utilizingSRC’s Potash ICP Analysis package designed for multi-element analysis of potashsamples. SRC includes blanks, duplicatesand their internal potash 003/004 standards in the analysis. SRC’s analytical procedures have been morefully detailed in the NI 43-101 Technical Report, dated 30 March 2012, preparedfor Passport Potash by ERCOSPLAN Ingenieurgesellschaft Geotechnik un BergbaumbH. SRC is an ISO/IEC 17025:2005 certified facility.
Onbehalf of the Board of Directors
PASSPORTPOTASH INC.
JoshuaBleak, President
Thisnews release includes certain statements that may be deemed”forward-looking statements”. All statements in this release, otherthan statements of historical facts, including the likelihood of commercialmining and possible future financings are forward-looking statements. Althoughthe Company believes the expectations expressed in such forward-lookingstatements are based on reasonable assumptions, such statements are notguarantees of future performance and actual results or developments may differmaterially from those in the forward-looking statements. Factors that couldcause actual results to differ materially from those in forward-lookingstatements include unsuccessful exploration results, changes in metals prices,changes in the availability of funding for mineral exploration, unanticipatedchanges in key management personnel and general economic conditions. Mining isan inherently risky business. Accordingly the actual events may differmaterially from those projected in the forward-looking statements. For moreinformation on the Company and the risks and challenges of its business,investors should review the Company’s annual filings that are availableat www.sedar.com.
NeitherTSX Venture Exchange nor its Regulation Services Provider (as that term isdefined in the policies of the TSX Venture Exchange) accepts responsibility forthe adequacy or accuracy of this release.
Contact:
Passport Potash Inc.
Peter J. Kletas
Manager of Corporate Development
866-999-6251-Toll Free
peter@passportpotash.com
Passport Potash Inc.
Clive Mostert
Corporate Communications
780-920-5044
cmostert@passportpotash.com
www.passportpotash.com
Link to OTC Markets Group – News, Filings & Corporate Actions
What small cap stocks (particularly $4-$8 range) are YOU waiting to pop?
For example, I own a stock which I am waiting until Friday for it to release information on setting an IPO date for a company it has a stake in in Sweden. I expect this stock to surge when that news is released.
Why do I always hear people saying penny stocks are bad?
They’re not really bad if you stick it out with them in the long term. It’s almost a guarantee if you wait years for it t move up. I think people are just impatient and want immediate results and somethings in life don’t go that way. It’s all about patience. I have lots of money in penny stocks and even If I have to wait years to see that money come in then so be it. I’ll have a lot of proftit by then as well.
BullQuake: $OSUR is gapping up this morning on: FDA Panel Votes 17-0 In Favor of Safety, Effectiveness of OraSure’s At-Home HIV Test
BullQuake: $OSUR is gapping up this morning on: FDA Panel Votes 17-0 In Favor of Safety, Effectiveness of OraSure’s At-Home HIV Test
Link to Twitter / BullQuake
